Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Saved in:
| Title: | Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. |
|---|---|
| Authors: | Xue, Weisong1,2,3 (AUTHOR), Wang, Ting1 (AUTHOR), Yao, Jiaxin1 (AUTHOR), Wu, Wei1 (AUTHOR), Chen, Dexin1 (AUTHOR), Yan, Botao1 (AUTHOR), Dong, Xiaoyu1 (AUTHOR), Tang, Yuting1 (AUTHOR), Zeng, Yunli1 (AUTHOR), He, Yueyu1 (AUTHOR), Cao, Peihua4 (AUTHOR), Shao, Fangyuan5 (AUTHOR), Huang, Wenhua6 (AUTHOR) huangwenhua2009@139.com, Deng, Chuxia5 (AUTHOR) cxdeng@um.edu.mo, Yan, Jun1,2,3 (AUTHOR) yanjunfudan@163.com |
| Source: | Bioengineering & Translational Medicine. Nov2023, Vol. 8 Issue 6, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23806761 |
|---|---|
| DOI: | 10.1002/btm2.10586 |
